Fresh Tracks Therapeutics... (FRTX)
NASDAQ: FRTX
· Real-Time Price · USD
0.94
0.00 (0.00%)
At close: Feb 28, 2025, 12:19 PM
Fresh Tracks Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 7.94M | 53K | 9K | 2.05M | 486K | 4.32M | 92K | 104K | 132K | 151K | 17K |
Cost of Revenue | n/a | n/a | 609K | 1.94M | 2.6M | 3.56M | 1.86M | 6.01M | 3.12M | 10.22M | 8.84M | 6.05M |
Gross Profit | n/a | 7.94M | -556K | -1.93M | -555K | -3.07M | 2.45M | -5.92M | -3.02M | -10.09M | -8.69M | -6.04M |
Operating Income | -1.65M | 2M | -2.36M | -4.34M | -4.59M | -6.08M | -1.46M | -9.41M | -6.3M | -13.36M | -11.58M | -9M |
Interest Income | n/a | n/a | 2K | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.24M | 1.91M | -2.28M | -4.28M | -4.53M | -6.02M | -1.15M | -9.41M | -6.07M | -13.25M | -11.15M | -9.01M |
Net Income | -1.24M | 2.1M | -2.28M | -4.21M | -4.53M | -5.96M | -836K | -9.41M | -6.07M | -13.25M | -11.15M | -9.01M |
Selling & General & Admin | 1.64M | 5.32M | 1.81M | 2.41M | 4.04M | 3M | 3.91M | 3.49M | 3.29M | 3.27M | 2.89M | 2.97M |
Research & Development | 10K | 627K | 609K | 1.94M | 2.6M | 3.56M | 1.86M | 6.01M | 3.12M | 10.22M | 8.84M | 6.05M |
Other Expenses | n/a | n/a | 82K | 68K | n/a | 58K | 313K | 1K | n/a | 107K | 459K | 31K |
Operating Expenses | 1.65M | 5.95M | 2.42M | 4.35M | 6.64M | 6.56M | 5.77M | 9.5M | 6.41M | 13.49M | 11.73M | 9.02M |
Interest Expense | n/a | n/a | 2K | 3K | 3K | n/a | 2K | 4K | 4K | 1K | 30K | 34K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.65M | 5.95M | 2.42M | 4.35M | 6.64M | 6.56M | 5.77M | 9.5M | 6.41M | 13.49M | 11.73M | 9.02M |
Income Tax Expense | n/a | -11K | n/a | -62K | n/a | -58K | -311K | 3K | 4K | 1K | 30K | 34K |
Shares Outstanding (Basic) | 5.91M | 5.91M | 5.91M | 3.76M | 3.01M | 2.91M | 2.66M | 2.65M | 2.4M | 1.85M | 1.53M | 1.36M |
Shares Outstanding (Diluted) | 5.91M | 5.91M | 5.91M | 3.76M | 3.01M | 2.91M | 2.66M | 2.65M | 2.4M | 1.85M | 1.53M | 1.36M |
EPS (Basic) | -0.21 | 0.32 | -0.39 | -1.12 | -1.5 | -2.05 | -0.31 | -3.55 | -2.53 | -7.15 | -7.29 | -6.63 |
EPS (Diluted) | -0.21 | 0.32 | -0.39 | -1.12 | -1.5 | -2.05 | -0.31 | -3.55 | -2.53 | -7.15 | -7.29 | -6.63 |
EBITDA | -1.23M | 2M | -2.27M | -4.26M | -4.51M | -6.01M | -1.14M | -9.4M | -6.06M | -13.24M | -11.11M | -8.97M |
EBIT | -1.24M | 2.1M | -2.28M | -4.27M | -4.52M | -6.02M | -1.15M | -9.41M | -6.06M | -13.25M | -11.12M | -8.97M |
Depreciation & Amortization | 10K | 11K | 10K | 10K | 9K | 8K | 6K | 7K | 7K | 7K | 7K | 1K |